ONdrugDelivery provides it’s readers with the latest industry information, intelligence and insights about the ideas, technologies, services and products the global pharma and biopharma sector are developing.
As a growing number of biologics are seeing their patent-exclusivity period expire, the window of opportunity for biosimilars to enter the market continues to expand. The increased competition that will ensue typically entails a reduction in the cost of the affected therapies. So, is there room for innovation? Find out more on page 24-25.